Stay updated on Avutometinib Combo in KRAS G12C NSCLC Clinical Trial

Sign up to get notified when there's something new on the Avutometinib Combo in KRAS G12C NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Avutometinib Combo in KRAS G12C NSCLC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Site revision note updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T21:23:35.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    22 days ago
    No Change Detected
  4. Check
    36 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.1 to v3.4.2. This appears to be a minor site update with no changes to study details or functionality.
    Difference
    0.0%
    Check dated 2026-02-12T02:28:34.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Revision updated to v3.4.1; previous revision v3.4.0 was removed.
    Difference
    0.0%
    Check dated 2026-02-04T23:33:51.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Added a glossary toggle (Show glossary) and introduced labels 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'. Updated the page revision to v3.4.0, and removed the former wording 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-28T21:24:16.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The study status updated to Active, not recruiting (revision v3.3.4). A large portion of investigator contact information and names was removed from the page.
    Difference
    9%
    Check dated 2026-01-14T04:15:30.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Added a new 'Locations' section listing recruitment sites across Colorado, District of Columbia, Illinois, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Ohio, Pennsylvania, Texas, Virginia, and Washington; revision updated to v3.3.3.
    Difference
    0.8%
    Check dated 2025-12-23T20:40:46.000Z thumbnail image

Stay in the know with updates to Avutometinib Combo in KRAS G12C NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Avutometinib Combo in KRAS G12C NSCLC Clinical Trial page.